Thursday, 15 May 2014

Dengue Market Research Reports and Pipeline Review


Global Markets Directs, Dengue - Pipeline Review, H1 2014, provides an overview of the Dengue therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by medicine target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dengue and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational medicines from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Medicine profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

* The report provides a snapshot of the global therapeutic landscape of Dengue
* The report reviews key pipeline products under medicine profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
* The report reviews key players involved in the therapeutics development for Dengue and enlists all their major and minor projects
* The report summarizes all the dormant and discontinued pipeline projects
* A review of the Dengue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
* A detailed assessment of monotherapy and combination therapy pipeline projects
* Coverage of the Dengue pipeline on the basis of target, MoA, route of administration and molecule type
* Latest news and deals relating related to pipeline products


Reasons to buy

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Develop strategic initiatives by understanding the focus areas of leading companies
* Identify and understand important and diverse types of therapeutics under development for Dengue
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Devise corrective measures for pipeline projects by understanding Dengue pipeline depth and focus of Indication therapeutics
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Dengue Market Research Reports and Pipeline Review


RELATED VIDEO:

Kidney Disease Market Research Reports and Pipeline Review


Global Markets Directs, Kidney Disease - Pipeline Review, H1 2014, provides an overview of the Kidney Diseases therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Kidney Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Disease and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

* The report provides a snapshot of the global therapeutic landscape of Kidney Disease
* The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
* The report reviews key players involved in the therapeutics development for Kidney Disease and enlists all their major and minor projects
* The report summarizes all the dormant and discontinued pipeline projects
* A review of the Kidney Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
* A detailed assessment of monotherapy and combination therapy pipeline projects
* Coverage of the Kidney Disease pipeline on the basis of target, MoA, route of administration and molecule type
* Latest news and deals relating related to pipeline products


Reasons to buy

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Develop strategic initiatives by understanding the focus areas of leading companies
* Identify and understand important and diverse types of therapeutics under development for Kidney Disease
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Devise corrective measures for pipeline projects by understanding Kidney Disease pipeline depth and focus of Indication therapeutics
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Kidney Disease Market Research Reports and Pipeline Review


RELATED VIDEO:

Wednesday, 14 May 2014

Fatigue Market Research Reports and Pipeline Review


Global Markets Directs, Fatigue - Pipeline Review, H1 2014, provides an overview of the Fatigues therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Fatigue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fatigue and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

* The report provides a snapshot of the global therapeutic landscape of Fatigue
* The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
* The report reviews key players involved in the therapeutics development for Fatigue and enlists all their major and minor projects
* The report summarizes all the dormant and discontinued pipeline projects
* A review of the Fatigue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
* A detailed assessment of monotherapy and combination therapy pipeline projects
* Coverage of the Fatigue pipeline on the basis of target, MoA, route of administration and molecule type
* Latest news and deals relating related to pipeline products


Reasons to buy

* Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Develop strategic initiatives by understanding the focus areas of leading companies
* Identify and understand important and diverse types of therapeutics under development for Fatigue
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
* Devise corrective measures for pipeline projects by understanding Fatigue pipeline depth and focus of Indication therapeutics
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


To order this report:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


RELATED LINK:

Fatigue Market Research Reports and Pipeline Review


RELATED VIDEO:

Tuesday, 13 May 2014

Retail Saving in the UK, Key Trends and Opportunities to 2018


Synopsis

This report provides market analysis, information and insights into the UK retail savings market:
* It provides a breakdown of the different forms of retail savings in the UK
* It analyses drivers and the outlook for the market
* It provides information on the main banks in the UK market
* It covers news and regulatory developments


Summary

Consumers' increasing saving motivations since the recession has led to five consecutive years of moderate growth in the retail savings industry, despite low interest rates, high unemployment and lower wages.


Scope

* This report provides market analysis, information and insights into the UK retail savings market:
* It provides a breakdown of the different forms of retail savings in the UK
* It analyses drivers and the outlook for the market
* It provides information on the main banks in the UK market
* It covers news and regulatory developments


Reasons to Buy

Gain an understanding of the UK retail savings industry


Key Highlights

Consumers' increasing saving motivations since the recession has led to five consecutive years of moderate growth in the retail savings industry, despite low interest rates, high unemployment and lower wages.


To order this report:

Email: support@researchonunitedkingdom.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600


RELATED LINK:




RELATED VIDEO:

Business Intelligence and Analytics Market in India 2014


Netscribes latest market research report titled Business Intelligence and Analytics Market in India 2014 captures the current scenario of the Business Intelligence and Analytics market in India. Continual rise in trading and business activity across the globe has resulted in the formulation of vast amount of digital data, which if analyzed efficiently can produce valuable insights and statistics. Consequently a major chunk of both large as well as smaller enterprises are constantly looking forward to equip themselves with sophisticated tools and applications which can tap this large data set and convert them into intelligent reports.

Over the past couple of years, social media domain has witnessed an exponential growth in the country which in turn has contributed largely in the accumulation of digital data. Highly valuable information pertaining to customers and related stake holders such as consumer behavior, purchase pattern, and product feedback, has become a major source of gathering raw data and information which is then taken as an input for business intelligence and analysis tools so as to generate insights and statistics at a very granular level.


Coverage

* Overview of the Business Intelligence and Analytics market in India and forecasted market size data over 2013 to 2018
* Qualitative analysis of market drivers, challenges, trends, cost & best practices and adoption across key sectors in India
* Overview of the market trends and differentiating past and current business strategies
* Analysis of the competitive landscape and detailed profiles of major players


Why Buy

* Get a clear understanding of the Business Intelligence and Analytics market in India, market dynamics and the various stages of the value chain
* Understand the current market scenario and future growth potential of the market in India till 2018 and plan strategies to gain from it
* Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market
* Understand your competitors business structures, strategies and prospects, and respond accordingly
* Make more informed business decisions with the help of insightful recommendations provided to succeed in the market


To order this report:

Email: support@researchonindia.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600


RELATED LINK:




RELATED VIDEO:

Monday, 12 May 2014

Telecom Equipment Market in India 2014


Netscribes latest market research report titled Telecom Equipment Market in India 2014 highlights the countrys wireless subscriber base that is growing at a rapid pace. With the fall in the prices of mobile devices, the popularity of end-user telecom equipment is also rising significantly. With the rising usage of 3G services and adoption of 4G technology, the need for telecom equipment is expected to rise significantly. Some government policies such as the IPv4 to IPv6 migration have also provided a significant boost to the domestic telecom industry. High imports signify the continued demand for telecom equipment in Indian markets which cannot be fulfilled by domestic production.

Currently, the Carrier Equipment segment generates the maximum revenue, although the future of the Enterprise Equipment segment looks promising. Revenue from user devices is expected to remain almost flat. Mobile handsets account for around 40% of the total telecom equipment market in India. The arrival of next generation 4G telecom network technologies and broadband wireless access have together resulted in a rapid increase in the demand for telecom equipment. Rural market is expected to be the future key growth driver for the Indian telecom sector, given the countrys growing rural population and disposable income. Currently, the rural wireless subscriber base comprises around 38.94% of the countrys total subscriber base.


Coverage

* Overview of the telecom equipment market in India and forecasted market size data over 2013 - 2017
* Growth in wireless subscriber base forecasted over 2013 - 2016 and subscribers of 3G Services in 2013 and forecasted over 2014 - 2017
* Total internet users in 2013 and forecasted growth rate over 2013 - 2020
* Qualitative analysis of the major drivers and challenges affecting the market
* Market dynamics through major trends
* Analysis of the competitive landscape and detailed profiles of major public and private players


Why Buy

* Get a broad understanding of the telecom equipment market in India, the dynamics of the market and current state of the same
* Be informed regarding the major trends for telecom equipment market and the prime opportunity areas
* Know which market is expected to be the next key growth drivers for the Indian telecom sector
* Get to know the roles and objectives of primary government bodies and what initiatives and progressive reforms are being taken to improve the Indian telecom equipment market
* Find out the major challenges in the sector to be well prepared before entering the market
* Understand major competitors business, market dynamics, and respond accordingly
* Make more informed business decisions with the help of insightful recommendations provided to succeed in the market


To order this report:

Email: support@researchonindia.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonindia.com


RELATED LINK:

Telecom Equipment Market in India 2014


RELATED VIDEO:

Ready to Eat Market in India 2014


Netscribes latest market research report titled Ready to Eat Market in India 2014 highlights the rising demand for Ready to Eat products in India due to the increasing levels of income of its vast population and their hectic lifestyles. The Ready to Eat products sector can be categorized into two broad segments, frozen products and shelf stable products that are available in the form of dinner/breakfast items and desserts/snacks. Consumer survey shows that there is a high demand for both the segments. RTE products are easy to use as they require minimum time for cooking such as re-heating to a desired temperature or the addition of water.

The rise in fruit and vegetable prices has helped RTE products to emerge as an easy substitute for consumers as they tend to be comparatively cheaper. The growing retail market is another major reason for the expansion of the RTE market. The growth rate and revenue is expected to be high over the next five years. The market is dominated by a private foreign player. With the expansion of the market, more and more players are venturing into this segment. Given their hectic lifestyles, more and more consumers are opting for RTE food products, thereby offering tremendous growth prospects for the players involved.


Coverage

* Overview of the ready to eat sector in India
* Overview of ready to eat market in India and historical and forecasted market size data over FY 2013 to FY 2018e
* Analysis of the ready to eat value chain and market segmentation
* Consumer insights on ready to eat products
* Export-import overview of ready to eat products, value and volume of export-import over 2010-11 to 2013-14(Apr-Dec) and country-wise value of export-import for 2013
* Qualitative analysis of market drivers, challenges, government policies, government participation and key trends
* Analysis of the competitive landscape and detailed profiles of major players
* Overview of the strategic recommendation


Why Buy

* Get a clear understanding of historical development, current market situation and future growth prospects of the ready to eat market in India
* Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market and purchase decisions of buyers
* Understand your competitors business structures, strategies and prospects, and respond accordingly
* Position yourself to gain maximum advantage by strategizing business models with a complete understanding of the business structures and strategies of competitors


To order this report:

Email: support@researchonindia.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonindia.com


RELATED LINK:

Ready to Eat Market in India 2014


RELATED VIDEO: